Literature DB >> 30121857

Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review.

Bark Betzel1, Joost P H Drenth2, Peter D Siersema2.   

Abstract

A systematic review was conducted on adverse events (AEs) associated with the use of the duodenal-jejunal bypass liner (DJBL). PubMed, EMBASE, and Cochrane library were searched up to January 2018. The quality of reporting AEs was determined by the McHarm questionnaire and the risk of bias by the Newcastle-Ottawa scale. Thirty-eight studies were included. The comparability of the studies was low and the McHarm questionnaire showed incompleteness for most parameters in all studies. A total of 891 AEs were reported in 1056 patients. Thirty-three AEs (3.7%) were classified as severe, including hepatic abscess and esophageal perforation. The anchor of the DJBL caused or likely caused 85% of the SAEs. To improve the safety margin of the DJBL, adjustments to the anchoring system are needed.

Entities:  

Keywords:  Acute pancreatitis; Adverse events; Duodenal-jejunal bypass liner; Endobarrier; Gastrointestinal hemorrhage; Hepatic abscess; Migration; Obstruction; Perforation

Mesh:

Year:  2018        PMID: 30121857     DOI: 10.1007/s11695-018-3441-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  17 in total

1.  For Debate: Should Bariatric Surgery be Performed in Children and Adolescents with Hypothalamic Obesity?

Authors:  Sarka Stolbova; Marek Benes; Lenka Petruzelkova; Jan Lebl; Stanislava Kolouskova
Journal:  Pediatr Endocrinol Rev       Date:  2017-06

2.  A lexicon for endoscopic adverse events: report of an ASGE workshop.

Authors:  Peter B Cotton; Glenn M Eisen; Lars Aabakken; Todd H Baron; Matt M Hutter; Brian C Jacobson; Klaus Mergener; Albert Nemcek; Bret T Petersen; John L Petrini; Irving M Pike; Linda Rabeneck; Joseph Romagnuolo; John J Vargo
Journal:  Gastrointest Endosc       Date:  2010-03       Impact factor: 9.427

Review 3.  Endoscopic bariatric therapies.

Authors:  Barham K Abu Dayyeh; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Nitin Kumar; Michael Larsen; Shelby Sullivan; Christopher C Thompson; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2015-03-28       Impact factor: 9.427

4.  Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner.

Authors:  Bark Betzel; Parviez Koehestanie; Jens Homan; Edo O Aarts; Ignace M C Janssen; Hans de Boer; Peter J Wahab; Marcel J M Groenen; Frits J Berends
Journal:  Gastrointest Endosc       Date:  2016-07-21       Impact factor: 9.427

5.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

6.  Outcome of self-expandable metallic stent deployment in patients with malignant gastroduodenal outlet obstruction and Niti-S and WallFlex comparison: a multicenter retrospective clinical study.

Authors:  Hironari Kato; Hirofumi Kawamoto; Kazuya Matsumoto; Ichiro Moriyama; Hideki Kamada; Koichiro Tsutsumi; Daisuke Goto; Nobuhiko Fukuba; Kiyohito Kato; Hiroki Sonoyama; Hajime Isomoto; Hiroyuki Okada
Journal:  J Dig Dis       Date:  2016-08       Impact factor: 2.325

7.  Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.

Authors:  Charlotte de Jonge; Sander S Rensen; Ger H Koek; Mandy F Joosten; Wim A Buurman; Nicole D Bouvy; Jan Willem M Greve
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-03       Impact factor: 11.382

8.  Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial.

Authors:  Marjolein Y V Homs; Peter J Wahab; Ernst J Kuipers; Ewout W Steyerberg; Tim A Grool; Jelle Haringsma; Peter D Siersema
Journal:  Gastrointest Endosc       Date:  2004-11       Impact factor: 9.427

Review 9.  The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review.

Authors:  Ingrid Zechmeister-Koss; Mirjana Huić; Stefan Fischer
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

10.  Impact of Duodenal-Jejunal Exclusion on Satiety Hormones.

Authors:  Charlotte de Jonge; Sander S Rensen; Froukje J Verdam; Royce P Vincent; Steve R Bloom; Wim A Buurman; Carel W le Roux; Nicole D Bouvy; Jan Willem M Greve
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

View more
  9 in total

Review 1.  Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope?

Authors:  Jad Farha; Shahem Abbarh; Zadid Haq; Mohamad I Itani; Andreas Oberbach; Vivek Kumbhari; Dilhana Badurdeen
Journal:  Curr Gastroenterol Rep       Date:  2020-11-17

Review 2.  The Role of Minimally Invasive and Endoscopic Technologies in Morbid Obesity Treatment: Review and Critical Appraisal of the Current Clinical Practice.

Authors:  Francesco Maria Carrano; Miroslav P Peev; John K Saunders; Marcovalerio Melis; Valeria Tognoni; Nicola Di Lorenzo
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

3.  Daily transient coating of the intestine leads to weight loss and improved glucose tolerance.

Authors:  Tammy Lo; Yuhan Lee; Chung-Yi Tseng; Yangshuo Hu; Margery A Connelly; Christos S Mantzoros; Jeffrey M Karp; Ali Tavakkoli
Journal:  Metabolism       Date:  2021-10-21       Impact factor: 8.694

4.  Effect of Novel Gastro-Duodenal Flow Restrictor on Relative Weight Loss and Glucose Levels in a Porcine Model: A Pilot Randomized Study.

Authors:  Gunn Huh; Jinhee Kwon; So Hee Kim; Ha Jong Lim; Se Hee Min; Do Hyun Park
Journal:  Nutrients       Date:  2022-06-21       Impact factor: 6.706

5.  Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis.

Authors:  Shi-Yan Lee; Haoxing Lai; Yang Jie Chua; Min Xian Wang; Guan-Huei Lee
Journal:  Front Med (Lausanne)       Date:  2022-05-09

6.  Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial.

Authors:  Norbert Joachim Tripolt; Felix Aberer; Jasmin Url; Christoph Högenauer; Florian Schreiber; Andreas Eherer; Caren Sourij; Anna-Maria Obermayer; Vanessa Stadlbauer; Eva Svehlikova; Martina Brunner; Harald Kojzar; Peter Nikolaus Pferschy; Thomas Rudolf Pieber; Harald Sourij
Journal:  Diabetes Ther       Date:  2018-12-11       Impact factor: 2.945

Review 7.  Bariatric and Metabolic Endoscopy: A New Paradigm.

Authors:  Andrea Telese; Vinay Sehgal; Cormac G Magee; S Naik; S A Alqahtani; L B Lovat; Rehan J Haidry
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

Review 8.  Procedures and devices for bariatric and metabolic endoscopy.

Authors:  Beatrice Orlandini; Camilla Gallo; Ivo Boškoski; Vincenzo Bove; Guido Costamagna
Journal:  Ther Adv Gastrointest Endosc       Date:  2020-06-03

Review 9.  Bariatric and metabolic endoscopy: impact on obesity and related comorbidities.

Authors:  Amit Mehta; Reem Z Sharaiha
Journal:  Ther Adv Gastrointest Endosc       Date:  2021-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.